Lipid-covered drug particles: Combined action of dioctadecyldimethylammonium bromide and amphotericin B or miconazole

Journal of Antimicrobial Chemotherapy

Volumn 58, Issue 1, 2006, Pages 66-75

  Lincopan, Nilton ^a   Carmona Ribeiro, Ana M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antifungal activity; Bilayer covered drug particle; Chaotropic effect; Synergism

Indexed keywords

AMPHOTERICIN B; DIMETHYLDIOCTADECYLAMMONIUM BROMIDE; MICONAZOLE; PERMANGANATE POTASSIUM;

ANTIFUNGAL ACTIVITY; ARTICLE; BINDING AFFINITY; CANDIDA ALBICANS; COLONY FORMING UNIT; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DISPERSION; DRUG MIXTURE; FUNGICIDAL ACTIVITY; IN VITRO STUDY; LIGHT SCATTERING; NONHUMAN; PARTICLE SIZE; STATISTICAL SIGNIFICANCE; ZETA POTENTIAL;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CHEMISTRY, PHARMACEUTICAL; DRUG COMBINATIONS; LIPIDS; MICONAZOLE; MOLECULAR STRUCTURE; PARTICLE SIZE; QUATERNARY AMMONIUM COMPOUNDS; SURFACE-ACTIVE AGENTS;

EID: 33748088505     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl153     Document Type: Article

References (31)

1. Zaoutis TE, Argon J, Chu J et al. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: A propensity analysis. Clin Infect Dis 2005; 41: 1232-9.
2. Richardson MD. Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 2005; 56 Suppl 1: I5-11.
3. Nucci M, Colombo AL, Silveira F et al. Risk factors for death in patients with candidemia. Infect Control Hosp Epidemiol 1998; 19: 846-50.
4. Arikan S, Rex JH. Lipid-based antifungal agents: Current status. Curr Pharm Des 2001; 7: 393-415.
5. Carmona-Ribeiro AM. Bilayer-forming synthetic lipids: Drugs or carriers? Curr Med Chem 2003; 10: 2425-46.
6. Carmona-Ribeiro AM, Vieira DB, Lincopan N. Cationic surfactants and lipids as anti-infective agents. Anti-Infect Agents Med Chem 2006; 5: 33-54.
7. Vieira DB, Carmona-Ribeiro AM. Synthetic bilayer fragments for solubilization of amphotericin B. J Colloid Interface Sci 2001; 244: 427-31.
8. Pacheco LF, Carmona-Ribeiro AM. Effects of synthetic lipids on solubilization and colloid stability of hydrophobic drugs. J Colloid Interface Sci 2003; 258: 146-54.
9. Lincopan N, Mamizuka EM, Carmona-Ribeiro AM. In vivo activity of a novel amphotericin B formulation with synthetic cationic bilayer fragments. J Antimicrob Chemother 2003; 52: 412-8.
10. Lincopan N, Mamizuka EM, Carmona-Ribeiro AM. Low nephrotoxicity of an effective amphotericin B formulation with cationic bilayer fragments. J Antimicrob Chemother 2005; 55: 727-34.
11. Johansson E, Engvall C, Arfvidsson M et al. Development and initial evaluation of PEG-stabilized bilayer disks as novel model membranes. Biophys Chem 2005; 113: 183-92.
12. Frenkel YV, Clark AD Jr, Des K et al. Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability. J Med Chem 2005; 48: 1974-83.
13. Chupin V, de Kroon AIPM, de Kruijff B. Molecular architecture of nanocapsules, bilayer-enclosed solid particles of cisplatin. J Am Chem Soc 2004; 126: 13816-21.
14. Burger KNJ, Staffhorst RWHM, de Vijlder HC et al. Nanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicity. Nat Med 2002; 8: 81-4.
15. Vieira DB, Pacheco LF, Carmona-Ribeiro AM. Assembly of a model hydrophobic drug into cationic bilayer fragments. J Colloid Interface Sci 2006; 293: 240-7.
16. Helmerhorst EJ, Reijnders IM, van't Hof W et al. A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides. FEBS Lett 1999; 449: 105-10.
17. Wei GX, Bobek LA. In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole. J Antimicrob Chemother 2004; 53: 750-8.
18. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts - Second Edition: Approved Standard M27-A2. NCCLS, Villanova, PA, USA, 2002.
19. Carmona-Ribeiro AM, Chaimovich H. Preparation and characterization of large dioctadecyldimethylammonium chloride liposomes and comparison with small sonicated vesicles. Biochim Biophys Acta 1983; 733: 172-9.
20. Carmona-Ribeiro AM. Synthetic amphiphile vesicles. Chem Soc Rev 1992; 21: 209-14.
21. Schales O, Schales SS. A simple and accurate method for the determination of chloride in biological fluids. J Biol Chem 1941; 140: 879-84.
22. Grabowski E, Morrison I. Particle size distribution from analysis of quasi-elastic light scattering data. In: Dahneke B, ed. Measurements of Suspended Particles by Quasi-Elastic Light Scattering. New York: Wiley-Interscience, 1983; 199-236.
23. Campanhã MTN, Mamizuka EM, Carmona-Ribeiro AM. Interactions between cationic vesicles and Candida albicans. J Phys Chem B 2001; 105: 8230-6.
24. Knapp C, Moody JA. Tests to assess bactericidal activity. In: Isenberg HD, ed. Clinical Microbiology Procedures Handbook. Washington: American Society for Microbiology, 1992; 1-33.
25. Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 2003; 52: 1.
26. Collins KD. Ions from the Hofmeister series and osmolytes: Effects on proteins in solution and in the crystallization process. Methods 2004; 34: 300-11.
27. Moelbert S, Normand B, De Los Rios P. Kosmotropes and chaotropes: modeling preferential exclusion, binding and aggregate stability. Biophys Chem 2004; 112: 45-57.
28. Hribar B, Southall NT, Vlachy V et al. How ions affect the structure of water. J Am Chem Soc 2002; 124: 12302-11.
29. Kalra A, Tugcu N, Cramer SM et al. Salting-in and salting-out of hydrophobic solutes in aqueous salt solutions. J Phys Chem B 2001; 105: 6380-6.
30. Collins KD. Sticky ions in biological systems. Proc Natl Acad Sci USA 1995; 92: 5553-7.
31. Smith C, Cheers C. Synergism between active listeriolysin O and dimethyldioctadecylammonium bromide to activate CD8(+) T cells. Vaccine 2005; 23: 4481-8.